Description
GLASSIA INJECTION, 1125 MG VIA
First action · last action
2011-09-01 · 2011-09-01
Transactions
1
First transaction's obligation
$24,098
Base + all options value (sum of deltas)
$24,098
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2011-09-01+$24,098= $24,098
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2011-09-01 | +$24,098 | $24,098 | GLASSIA INJECTION, 1125 MG VIA |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI RSKLEFCZ6127)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25626P0776 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $22,990 | FY2026 |
| 36C26226N0708 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $387,926 | FY2026 |
| 36C26226D0102 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C26026P0469 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $114,588 | FY2026 |
| 36C24826N0573 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $30,000 | FY2026 |
| 36C24826A0015 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under 6505 from 504-AMARILLO (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA504P17975 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 504-AMARILLO | $5,405 | FY2011 |
| VA50417940 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 504-AMARILLO | $5,405 | FY2011 |
| VA504P17588 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 504-AMARILLO | $5,381 | FY2011 |
| VA504P17586 | PROCARE PHARMACY DIRECT, L.L.C. | 504-AMARILLO | $3,194 | FY2011 |
| VA504P17636 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 504-AMARILLO | $5,381 | FY2011 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA504A10058_3600_-NONE-_-NONE- · retrieved 2026-09-26.